Facility
Bachem - Bubendorf, Switzerland
Operated by Bachem Holding AG →CH
$1B+ expansion; more than doubling production capacity for GLP-1 peptide APIs; modular expansion phases through 2025+; primary CDMO hub for semaglutide generics/biosimilars
0
Inputs produced
0
Goods downstream
0
Incidents on record
0
Stories